A detailed history of Pinnacle Bancorp, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 493 shares of AMGN stock, worth $153,209. This represents 0.04% of its overall portfolio holdings.

Number of Shares
493
Previous 445 10.79%
Holding current value
$153,209
Previous $128,000 9.38%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $12,905 - $15,578
48 Added 10.79%
493 $140,000
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $5,466 - $6,786
25 Added 5.95%
445 $119,000
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $5,356 - $6,334
-25 Reduced 5.62%
420 $93,000
Q4 2022

Jan 24, 2023

SELL
$229.03 - $291.01 $2,748 - $3,492
-12 Reduced 2.63%
445 $117,000
Q2 2022

Jul 12, 2022

SELL
$230.71 - $256.74 $3,460 - $3,851
-15 Reduced 3.18%
457 $111,000
Q1 2022

Apr 14, 2022

BUY
$219.27 - $242.57 $5,701 - $6,306
26 Added 5.83%
472 $114,000
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $14,717 - $16,842
74 Added 19.89%
446 $100,000
Q2 2021

Jul 15, 2021

BUY
$233.58 - $259.14 $3,503 - $3,887
15 Added 4.2%
372 $91,000
Q4 2020

Jan 13, 2021

BUY
$216.38 - $257.67 $2,163 - $2,576
10 Added 2.88%
357 $82,000
Q3 2020

Oct 13, 2020

BUY
$234.65 - $260.95 $5,866 - $6,523
25 Added 7.76%
347 $88,000
Q1 2020

Apr 09, 2020

SELL
$182.24 - $241.7 $5,284 - $7,009
-29 Reduced 8.26%
322 $65,000
Q4 2019

Jan 10, 2020

BUY
$189.21 - $243.2 $5,487 - $7,052
29 Added 9.01%
351 $85,000
Q4 2018

Mar 20, 2019

BUY
$178.4 - $208.25 $57,444 - $67,056
322 New
322 $63,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pinnacle Bancorp, Inc. Portfolio

Follow Pinnacle Bancorp, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.